Penny Stock Alert: Advaxis, Inc. (ADXS)

Dust out the Arrows, Time To Aim High!!!

It’s been two weeks since our 91% winner with GEAR because we have been researching to find a stock that would perform better than GEAR did and hold that gain as well. has found a Biotech Company at the forefront in the fight against cervical cancer that we think is going to storm the markets strong on Monday. It’s under 10 cents and was awarded the the Best Therapeutic Vaccine by Novartis in April this year. (see here)

We Bring You: Advaxis, Inc., (ADXS)

PPS: $0.098 (current quote)
Market Cap: 28.07M
Shares Outstanding 286.47M a/o Mar 09, 2012
Float: 265.70M

Start your research here: SEC and ADXS Website

Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases.

In April 2012, ADXS’ ADXS-HPV was chosen as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence Awards by the vaccine industry and the journal Expert Reviews of Vaccines.

ADXS closed strong on Friday in antcipation of their clinical trials update at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL which is going on right now! See the press release here.

ADXS could easily double or even triple on Monday from its current levels after their expected positive results from their clinical studies of ADXS-HPV!

It wouldn’t be surprising if ADXS broke through these 3 technical levels:

0.2908: Price Crosses 9-18 Day Moving Average
0.3741: Price Crosses 9-40 Day Moving Average
0.5256: Price Crosses 18-40 Day Moving Average

This is a huge industry and the forefront against one of the top enemies we have: Cancer. The American Cancer Society estimates that there will be about 12,170 newly diagnosed cervical cancer cases in the U.S. in 2012. About 500,000 patients per year are diagnosed with high grade CIN (2-3), the predecessor condition to cervical cancer.

In 2009, the CDC reported that about 45% of women aged 20 to 24 had HPV. HPV causes a number of different types of cancer. The same types of genital HPV that cause cervical cancer (HPV-16, HPV-18) cause about 8 out of 10 squamous cell anal cancers. In addition, nearly half of cancers of the vulva and about 7 out of 10 vaginal cancers are HPV-related. Some other genital cancers (cancers of the penis and urethra) and some head and neck cancers (mostly the throat, tongue, and tonsils) are also related to high-risk types of HPV.

Monday is going to be huge with ADXS.

ADXS has 100% gains built in just to its 52-week high alone.

With the Biotech Boom that we’ve seen the last 2 weeks with ROSG, GNOM and PIP, it wouldn’t be surprising to see ADXS hit the 30 cent range.


***Reminder: never chase stocks that gap at the open and always protect your profits!

Good luck in making the Best Penny Stock picks.

2012 – Become a Millionaire!!


Want to Discover the “Next” Blue Chip while it is still under $1 and turn $1,000 into $50,000 or more!?

Subscribe to Aim High Profits Penny Stock Alerts Today. You will have unlimited free access to penny stock picks which will help guide you to some of the biggest and most profitable trading alerts and techniques proven to bring in the “big bucks“.

Visit to find out more about Good Penny Stocks to Watch and the Best Penny Stocks to Buy in the Stock Market Today.

For a review on the penny stock of SEFE Inc., click SEFE to get details from behind the curtain.

AimHighProfits’ due diligence will help to stay away from all the scams out there these days or at least help you to understand the risks involved with them!


Got Something to Say or Add......

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s